Astrocytes and temporal lobe epilepsy
星形胶质细胞和颞叶癫痫
基本信息
- 批准号:7535112
- 负责人:
- 金额:$ 19.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-08-01 至 2010-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAgonistAnimal ModelAnimalsAnticonvulsantsAstrocytesBrainBrain regionCalciumCellsChronicCorpus striatum structureDevelopmentEpilepsyEpileptogenesisExcitatory Amino Acid ReceptorsExhibitsFrequenciesGenerationsGlutamatesHippocampus (Brain)HumanImmunoblottingImmunohistochemistryKainic AcidKainic Acid ReceptorsKnowledgeLaboratoriesLeadLightMaintenanceMedialModelingMolecular TargetNeurogliaNeuronsNumbersPatch-Clamp TechniquesPathologicPhasePreparationPreventionProbabilityProcessProtein ArrayPublic HealthPyramidal CellsRattusReceptor ActivationRecurrenceResearchRoleSalineSeizuresSignaling MoleculeSliceStatus EpilepticusSynaptic plasticityTechniquesTemporal LobeTemporal Lobe EpilepsyTestingTheoretical modelTherapeuticUncertaintyWeekWestern BlottingWorkcell typedirect applicationentorhinal cortexexperienceimprovedinnovationkainatenovelpatch clampreceptor expressionresearch studyresponsetherapeutic targettherapy resistant
项目摘要
DESCRIPTION (provided by applicant): Temporal lobe epilepsy (TLE), a devastating seizure disorder that is difficult to control with anticonvulsant drugs, often develops following an initial insult to the CNS. In order to better understand the process of epileptogenesis and to develop innovative therapeutic approaches for the management of TLE, animal models have been developed that exhibit some of the hallmarks of this seizure disorder: a period of status epilepticus (SE) which serves as the initial insult to the CNS, a variable latent period during which seizures do not occur, and the eventual development of recurrent, spontaneous seizures of temporal lobe origin. Decades of research in such models have generated a vast amount of knowledge on the role of neurons in the hippocampus (HC) in TLE. However very little is currently known about the functional role in TLE of astrocytes: the other major cell type within the brain. Recently our laboratory utilized the kainic acid (KA) model of SE to investigate such `reactive' astrocytes. In this commonly used animal model of TLE, we made the novel discovery that astrocytes dramatically increase the expression of the ionotropic kainate receptor subunit, KA1. We hypothesize that activation of these newly expressed kainate receptors induces excitatory gliotransmission that depolarizes nearby CA1 pyramidal cells. Such excitatory gliotransmission in the hippocampus may have significant implications with respect to synchronization and seizure generation and this exploratory proposal will perform two specific aims to test this overall hypothesis. Specific Aim 1 will use immunohistochemical and immunoblotting techniques to determine if KA- induced SE results in a long-term increase in expression of kainate receptors on astrocytes. Specific Aim 2 will use the whole cell patch clamp technique to determine if activation of kainate receptors expressed on astrocytes induces gliotransmission that activates excitatory amino acid receptors in CA1 pyramidal cells in brain slices obtained from animals following KA-induced SE. It is anticipated that an increased understanding of the role of astrocytes in TLE will provide innovative molecular targets for the treatment of this frequently therapy-resistant seizure disorder. PUBLIC HEALTH RELEVANCE: Increasing evidence suggests that non-neuronal glial cells may contribute to seizure generation and epilepsy. Therefore, the proposed research will evaluate changes in a specific type of excitatory amino acid receptor that occur in glial cells in an animal model of epilepsy. It is anticipated that this work will reveal new potential therapeutic targets for the treatment of epilepsy.
描述(由申请人提供):颞叶癫痫(TLE)是一种难以用抗惊厥药物控制的破坏性癫痫发作疾病,通常在CNS初始损伤后发生。为了更好地了解癫痫发生的过程并开发用于管理TLE的创新治疗方法,已经开发了表现出这种癫痫发作障碍的一些特征的动物模型:癫痫持续状态(SE)期,其作为对CNS的初始损伤,可变的潜伏期,在此期间不发生癫痫发作,以及复发的最终发展,源于颞叶的自发性癫痫几十年的研究在这样的模型已经产生了大量的知识海马(HC)中的神经元在TLE中的作用。然而,目前对星形胶质细胞在TLE中的功能作用知之甚少:星形胶质细胞是大脑中的另一种主要细胞类型。最近,我们的实验室利用海人酸(KA)模型的SE调查这种“反应性”星形胶质细胞。在这个常用的TLE动物模型中,我们发现星形胶质细胞显著增加离子型红藻氨酸受体亚基KA1的表达。我们假设这些新表达的红藻氨酸受体的激活诱导兴奋性胶质传递,使附近的CA1锥体细胞去极化。这种兴奋性gliotransmission在海马体可能有显着的影响,同步和癫痫发作的产生,这个探索性的建议将执行两个具体的目标,以测试这一整体假设。具体目标1将使用免疫组织化学和免疫印迹技术来确定KA诱导的SE是否导致星形胶质细胞上红藻氨酸受体表达的长期增加。具体目标2将使用全细胞膜片钳技术来确定星形胶质细胞上表达的红藻氨酸受体的激活是否诱导胶质传递,其激活KA诱导SE后动物脑切片中CA 1锥体细胞中的兴奋性氨基酸受体。预期星形胶质细胞在TLE中的作用的增加的理解将提供用于治疗这种频繁的治疗抗性癫痫发作病症的创新分子靶点。公共卫生相关性:越来越多的证据表明,非神经胶质细胞可能有助于癫痫发作和癫痫。因此,拟议的研究将评估癫痫动物模型中神经胶质细胞中发生的特定类型兴奋性氨基酸受体的变化。预计这项工作将揭示治疗癫痫的新的潜在治疗靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Karen S Wilcox其他文献
Karen S Wilcox的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Karen S Wilcox', 18)}}的其他基金
Role of microglia in a novel model of temporal lobe epilepsy
小胶质细胞在颞叶癫痫新模型中的作用
- 批准号:
10392925 - 财政年份:2011
- 资助金额:
$ 19.75万 - 项目类别:
Role of microglia in a novel model of temporal lobe epilepsy
小胶质细胞在颞叶癫痫新模型中的作用
- 批准号:
10690897 - 财政年份:2011
- 资助金额:
$ 19.75万 - 项目类别:
Role of microglia in a novel model of temporal lobe epilepsy
小胶质细胞在颞叶癫痫新模型中的作用
- 批准号:
9918476 - 财政年份:2011
- 资助金额:
$ 19.75万 - 项目类别:
The Medial Entorhinal Cortex and Temporal Lobe Epilepsy
内侧内嗅皮层和颞叶癫痫
- 批准号:
6708388 - 财政年份:2003
- 资助金额:
$ 19.75万 - 项目类别:
The Medial Entorhinal Cortex and Temporal Lobe Epilepsy
内侧内嗅皮层和颞叶癫痫
- 批准号:
7023879 - 财政年份:2003
- 资助金额:
$ 19.75万 - 项目类别:
The Medial Entorhinal Cortex and Temporal Lobe Epilepsy
内侧内嗅皮层和颞叶癫痫
- 批准号:
6859396 - 财政年份:2003
- 资助金额:
$ 19.75万 - 项目类别:
The Medial Entorhinal Cortex and Temporal Lobe Epilepsy
内侧内嗅皮层和颞叶癫痫
- 批准号:
7192406 - 财政年份:2003
- 资助金额:
$ 19.75万 - 项目类别:
The Medial Entorhinal Cortex and Temporal Lobe Epilepsy
内侧内嗅皮层和颞叶癫痫
- 批准号:
6617397 - 财政年份:2003
- 资助金额:
$ 19.75万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 19.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 19.75万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 19.75万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 19.75万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 19.75万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 19.75万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 19.75万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 19.75万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 19.75万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 19.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)